InnoPharmax Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	97.28	166.73	39.36	40.53	90.51
Short-Term Investments	57.58	114.5	100.3	55.85	96.76
Cash & Short-Term Investments	154.86	281.23	139.66	96.37	187.26
Cash Growth	-44.93%	101.37%	44.91%	-48.54%	-22.58%
Accounts Receivable	1.83	4.53	6.96	-	-
Other Receivables	0.89	0.47	0.82	0.57	4.03
Receivables	2.72	5	7.78	0.57	4.03
Inventory	15.12	19.33	25.53	30.5	16.12
Prepaid Expenses	2.8	1.47	3.38	1.1	1.92
Other Current Assets	-	13.26	12.65	8.2	-
Total Current Assets	175.51	320.29	188.99	136.74	209.33
Property, Plant & Equipment	3.42	8.59	13.77	19.57	13.77
Long-Term Investments	251.32	261.21	269.14	278.43	283.97
Other Intangible Assets	5.27	6.22	6.72	8.85	9.75
Long-Term Accounts Receivable	-	-	6.09	6.09	6.09
Long-Term Deferred Tax Assets	15.89	19.4	21.72	21.72	21.72
Other Long-Term Assets	17.58	17.35	17.75	17.92	11.53
Total Assets	468.98	633.06	524.2	489.31	556.16
Accounts Payable	9.57	2.4	6.7	0.84	0.84
Accrued Expenses	-	0	0	0.23	0.04
Short-Term Debt	10	10	11.5	23.27	-
Current Portion of Leases	0.82	4.57	4.48	4.42	4.5
Current Unearned Revenue	3.64	2.44	0.18	0.18	0.18
Other Current Liabilities	25.78	9.98	11.09	10.19	8.66
Total Current Liabilities	49.81	29.4	33.95	39.13	14.22
Long-Term Leases	-	0.82	5.39	9.86	1.08
Other Long-Term Liabilities	-	-	9.32	9.32	9.32
Total Liabilities	49.81	30.22	48.65	58.31	24.61
Common Stock	1,076	1,076	949.97	868.36	867.19
Additional Paid-In Capital	100.43	100.43	34.17	0.77	52.86
Retained Earnings	-757.01	-572.96	-507.84	-437.48	-386.89
Comprehensive Income & Other	-	-0.44	-0.75	-0.66	-1.61
Shareholders' Equity	419.18	602.85	475.55	431	531.54
Total Liabilities & Equity	468.98	633.06	524.2	489.31	556.16
Total Debt	10.82	15.39	21.36	37.56	5.57
Net Cash (Debt)	144.04	265.84	118.29	58.82	181.69
Net Cash Growth	-45.82%	124.73%	101.12%	-67.63%	-14.29%
Net Cash Per Share	1.34	2.73	1.28	0.68	2.10
Filing Date Shares Outstanding	108.15	107.58	95	86.84	86.72
Total Common Shares Outstanding	108.15	107.58	95	86.84	86.72
Working Capital	125.7	290.89	155.05	97.61	195.11
Book Value Per Share	3.88	5.60	5.01	4.96	6.13
Tangible Book Value	413.91	596.62	468.82	422.15	521.8
Tangible Book Value Per Share	3.83	5.55	4.94	4.86	6.02
Machinery	-	35.67	35.14	34.74	36.97
Leasehold Improvements	-	0.66	0.66	0.66	0.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.